Clinical trial
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
NCT00295308 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 8, 2005
- Completion date
- July 30, 2014
- Enrollment
- 208 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.